🔗 Permalink

Inventor profile of:

Gregory Lambert

City:

Chatenay-Malabry

Country:

France

Published Applications:

Last publication date:

2023-06-15

Top Assignees for applications by Gregory Lambert

The entities that hold a legal rights for patent applications filed by inventor Lambert Gregory:

NOVAGALI PHARMA SA 16 Evry, France
SANTEN SAS 9 Evry, France
TARGEDYS 7 Rouen, France
Institut National De La Sante Et De La Recherche Medicale (INSERM) 3 Paris, France
UNIVERSITÉ DE ROUEN 3 Mont Saint-Aignan, France
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) 3 Paris Cedex 13, France
CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN 3 Rouen, France
UNIVERSITE DE ROUEN 2 Mont-Saint-Aignan, France
SOFIC (STE FRANCAISE D'INSTRUMENTS DE CHIRURGIE) 1 Mazamet, France
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) 1 Paris, France
NOVAGALIPHARMA SA 1 EVRY, France
Nova-Gali Pharma SA 1 Evry, France
NOVAGALI PHARMASA 1 Evry, France
SOFIC (STÉ FRANÇAISE D'INSTRUMENTS DE CHIRURGIE) 1 Mazamet, France
Novagli Pharma S.A. 1 Evry, France

Recent patent applications by Lambert Gregory

Gregory Lambert from Chatenay-Malabry, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-06-15

US20230181738A1

Human necessities

OIL-IN-WATER EMULSIONS COMPRISING CETALKONIUM CHLORIDE AND METHODS OF MAKING AND USING THE SAME

#2 | 2022-01-06

US20220000941A1

Human necessities

MINERAL ELEMENTS COMPRISING HAFNIA ALVEI COMPOSITIONS

#3 | 2021-12-30

US20210401020A1

Human necessities

HAFNIA ALVEI FORMULATIONS

#4 | 2021-04-15

US20210107952A1

Chemistry; metallurgy

protein extract and uses thereof

#5 | 2021-02-11

US20210038721A1

Human necessities

Oil-in-water emulsions comprising cetalkonium chloride and methods of making and using the same

#6 | 2021-01-14

US20210008125A1

Human necessities

Hafnia alvei impact on regulation of appetite and metabolic syndrome aspects

#7 | 2020-04-30

US20200131495A1

Chemistry; metallurgy

PROTEINS DERIVED FROM CLPB AND USES THEREOF

#8 | 2020-01-02

US20200000924A9

Human necessities

COMPOSITIONS CONTAINING QUATERNARY AMMONIUM COMPOUNDS

#9 | 2019-05-16

US20190142876A1

Human necessities

based pharmaceutical and food compositions for inducing satiation and prolonging satiety

#10 | 2019-01-24

US20190022231A1

Human necessities

Methods for preparing oil-in-water emulsions comprising cetalkonium chloride

#11 | 2018-12-27

US20180369378A1

Human necessities

Bacterial influence on regulation of appetite via ClpB protein mimicry of alpha-MSH

#12 | 2016-03-24

US20160082107A1

Human necessities

Emulsion compositions containing quaternary ammonium compounds

#13 | 2015-04-30

US20150119813A1

Human necessities

Sheath protecting a cannula, and safety syringe comprising said sheath

#14 | 2013-12-19

US20130337019A1

Human necessities

Emulsion compositions containing cetalkonium chloride

#15 | 2013-05-09

US20130115569A1

Human necessities

Method and Related Devices for Mixing Two Injectable Compositions Prior to Injection

#16 | 2011-08-18

US20110201689A1

Human necessities

Emulsion compositions containing quaternary ammonium compounds

#17 | 2011-01-27

US20110021443A1

Human necessities

Oil in water emulsion comprising NSAIDs and quaternary ammonium halides

#18 | 2010-11-11

US20100286065A1

Human necessities

Topical methods and compositions for the treatment of eye diseases and conditions

#19 | 2009-07-02

US20090170944A1

Human necessities

OPHTHALMIC MICELLAR COMPOSITIONS WITH ENHANCED STABILITY

#20 | 2009-07-02

US20090169629A1

Human necessities

MICELLAR COMPOSITIONS WITH OPHTHALMIC APPLICATIONS

#21 | 2009-05-14

US20090124565A1

Human necessities

Composition comprising at least one nucleosidic moiety as a therapeutic agent, and CKC

#22 | 2009-01-29

US20090028955A1

Human necessities

Ophthalmic emulsions containing an immunosuppressive agent

#23 | 2009-01-15

US20090018057A1

Human necessities

OIL IN WATER EMULSION COMPRISING NSAIDs AND QUATERNARY AMMONIUM HALIDES

#24 | 2008-10-30

US20080268020A1

Human necessities

Ophthalmic Emulsions Containing Prostaglandins

#25 | 2008-08-14

US20080194532A1

Human necessities

Compositions containing quaternary ammonium compounds

#26 | 2008-07-31

US20080181867A1

Human necessities

Process for manufacturing ophthalmic oil-in-water emulsions

#27 | 2008-05-08

US20080107738A1

Human necessities

Ophthalmic emulsions containing prostaglandins

#28 | 2008-01-31

US20080026991A1

Human necessities

Emulsion compositions containing quaternary ammonium compounds

#29 | 2008-01-31

US20080026013A1

Human necessities

Compositions containing quaternary ammonium compounds

#30 | 2008-01-31

US20080025941A1

Human necessities

Compositions containing quaternary ammonium compounds

#31 | 2007-12-06

US20070281914A1

Human necessities

Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye

#32 | 2007-12-06

US20070281913A1

Human necessities

Method for treating eye disease or conditions affecting the posterior segment of the eye

#33 | 2007-12-06

US20070280995A1

Human necessities

Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye

#34 | 2007-12-06

US20070280902A1

Human necessities

Method for treating eye disease or conditions affecting the posterior segment of the eye

#35 | 2007-10-25

US20070248645A1

Human necessities

Ophthalmic oil-in-water type emulsion with stable positive zeta potential

InventorID:

234876 ⎘